SCHEMBL1259243

SCHEMBL1259243

CO/C=C/C(=O)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1259244 1.00
SCHEMBL23227153 0.77
SCHEMBL4259758 0.77 KEAP1 (0.32)
SCHEMBL4259755 0.77 KEAP1 (0.32)
SCHEMBL10308367 0.76 GABRP (0.35)
SCHEMBL10308366 0.76 GABRP (0.35)
SCHEMBL14084988 0.75 TSHR (0.35)
SCHEMBL14769850 0.75
SCHEMBL29008703 0.72
SCHEMBL16922220 0.72 HCAR2 (0.65)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11952364-B2 TRK inhibitors useful as anticancer drugs TYLIGAND BIOSCIENCE (SHANGHAI) LIMITED (CN) 2024-04-09 US disclosed
CN-112739691-B TRK inhibitors as anticancer agents 泰励生物科技(上海)有限公司 2023-05-23 CN disclosed
US-20220388983-A1 TRK INHIBITORS USEFUL AS ANTICANCER DRUGS TYLIGAND BIOSCIENCE (SHANGHAI) LIMITED (CN) 2022-12-08 US disclosed
EP-3848365-A1 TRK INHIBITOR AS ANTI-CANCER DRUG Tyligand Bioscience (Shanghai) Limited (CN) 2021-07-14 EP disclosed
CN-112739691-A TRK inhibitors as anticancer agents 泰励生物科技(上海)有限公司 2021-04-30 CN disclosed
US-8445509-B2 Fused heterocyclic derivatives and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-05-21 US disclosed
US-20110046169-A1 FUSED HETEROCYCLIC DERIVATIVES AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-02-24 US disclosed
EP-1562902-B1 2-PYRIDONE DERIVATIVES AS INHIBITORS OF NEUTROPHILE ELASTASE ASTRAZENECA AB (SE) 2006-05-03 EP disclosed
US-20060035938-A1 2-Pyridone derivatives as inhibitors of neutrophile elastase ASRAZENECA AB (SE) 2006-02-16 US disclosed
US-20020198384-A1 Thienopyridine derivatives, their intermediates and production thereof MIKI SHOKYO (JP) 2002-12-26 US disclosed
US-6437132-B2 INHIBITOR OF GONADOTROPIN RELEASING HORMONE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2002-08-20 US disclosed
US-20020019529-A1 Thienopyridine derivatives, their intermediates and production thereof MIKI SHOKYO (JP) 2002-02-14 US disclosed
US-6329388-B2 GONADOTROPIN-RELEASING HORMONE ANTAGONIZING ACTIVITY; USEFUL FOR PREVENTING OR TREATING SEX HORMONE-DEPENDENT DISEASES, E.G., SEX HORMONE-DEPENDENT CANCERS (E.G., PROSTATIC CANCER, UTERINE CANCER, BREAST CANCER, PITUITARY TUMOR) TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-12-11 US disclosed
US-6313301-B1 CYCLIZATION; LUTEINIZING HORMONE RELEASING HORMONE INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-11-06 US disclosed
US-6297255-B1 GONADOTROPIN-RELEASING HORMONE ANTAGONIZING ACTIVITY; PREVENTING OR TREATING SEX HORMONE-DEPENDENT DISEASES TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-10-02 US disclosed
US-6262267-B1 HAS GONADOTROPIN-RELEASING HORMONE ANTAGONIZING ACTIVITY; USEFUL FOR PREVENTING OR TREATING SEX HORMONE-DEPENDENT DISEASES, E,G., SEX HORMONE-DEPENDENT CANCERS E.G., PROSTATIC CANCER, UTERINE CANCER, BREAST CANCER, PITUITARY TUMOR TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-07-17 US disclosed
US-20010001104-A1 Thienopyridine compounds, their production and use FURUYA SHUICHI (JP) 2001-05-10 US disclosed
EP-1004585-A1 THIENOPYRIDINE DERIVATIVES, INTERMEDIATES THEREOF, AND PROCESS FOR PRODUCING THE BOTH Takeda Chemical Industries, Ltd. (JP) 2000-05-31 EP disclosed